Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Recent & Breaking News (TSX:BHC)

Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses

PR Newswire August 18, 2020

Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE(TM) Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses

PR Newswire August 17, 2020

Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses

PR Newswire August 11, 2020

Bausch Health Companies Inc. Announces Second-Quarter 2020 Results

Canada NewsWire August 6, 2020

Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company

Canada NewsWire August 6, 2020

Bausch Health Resolves Canadian Securities Class Action

Canada NewsWire August 5, 2020

Bausch Health Resolves Legacy SEC Investigation

Canada NewsWire July 31, 2020

Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients

Canada NewsWire July 28, 2020

Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6

PR Newswire July 23, 2020

Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates

GlobeNewswire June 29, 2020

Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States

PR Newswire June 23, 2020

BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China

Canada NewsWire June 17, 2020

Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference

PR Newswire June 16, 2020

Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients

PR Newswire June 15, 2020

Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII(TM)

Canada NewsWire June 11, 2020

FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE(TM) Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses

PR Newswire June 4, 2020

Bausch + Lomb Announces The European Launch Of LuxSmart(TM) And LuxGood(TM) Preloaded Intraocular Lenses

PR Newswire May 27, 2020

Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference

PR Newswire May 21, 2020

Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization

Canada NewsWire May 11, 2020

Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes

Canada NewsWire May 11, 2020